Ai Day1 Llc Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity
Ai Day1 LLC is of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 12.9 Million shares of DAWN, which is worth approximately $166 Million. The most recent transaction as insider was on Oct 20, 2023, when has been sold 111,387 shares (Common Stock) at a price of $9.97 per share, resulting in proceeds of $1,110,528. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.9M
0%
3M change
0%
12M change
Total Value Held
$166 Million
AI Day1 LLC Transaction History
ADL
Ai Day1 LLC
New York, NY